adenosine monophosphate has been researched along with Thromboembolism, Venous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, J; Allada, V; Allen, B; Bacha, E; Diacovo, T; Diamond, S; Kreutzer, J; Krishnamurthy, G; Morell, V; Price, M; Schmidhofer, J; Vargas, D; Vincent, J; Yeh, J; Yu, X; Zhou, H | 1 |
| Berkman, SA; Tapson, VF | 1 |
1 review(s) available for adenosine monophosphate and Thromboembolism, Venous
| Article | Year |
|---|---|
COVID-19 and Its Implications for Thrombosis and Anticoagulation.
Topics: Adenosine Monophosphate; Alanine; Ambulatory Care; Antibodies, Antiphospholipid; Antibodies, Monoclonal, Humanized; Anticoagulants; Antirheumatic Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dose-Response Relationship, Drug; Drug Combinations; Duration of Therapy; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Ritonavir; SARS-CoV-2; Thrombolytic Therapy; Thrombophilia; Thrombosis; Venous Thromboembolism | 2021 |
1 other study(ies) available for adenosine monophosphate and Thromboembolism, Venous
| Article | Year |
|---|---|
Cangrelor PK/PD analysis in post-operative neonatal cardiac patients at risk for thrombosis.
Topics: Adenosine Monophosphate; Anticoagulants; Humans; Infant, Newborn; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Thrombosis; Venous Thromboembolism | 2021 |